Advanced Ophthalmic Innovations Pte Ltd (AOI) is headquartered in Singapore and is an ophthalmic medical technology company dedicated to developing innovative products and commercializing them to change the treatment methods for glaucoma.

We initially obtained an intellectual property (IP) license from the National University of Singapore (NUS) and successfully commercialized it, developing a first-class high-quality glaucoma drainage device. In just three years after obtaining EU CE certification, our flagship product has been welcomed and favored by many renowned glaucoma surgeons worldwide. Our sustained strong income growth in many countries in Europe, the Middle East, Asia Pacific, Africa, and Latin America further confirms this. We have conducted sales operations in over 50 countries worldwide. Our products are becoming increasingly popular in the treatment of advanced or drug-uncontrollable glaucoma. AOI will continue to collaborate with the National University of Singapore to further authorize and commercialize intellectual property rights, and develop a medical technology equipment portfolio for glaucoma treatment.

In addition, we also collaborate with relevant government agencies to develop a new generation of viscoelastic and collagen proteins suitable for ophthalmic applications. In addition, we also plan to conduct more research projects with higher education institutions to develop sustained-release drug platforms for glaucoma patients.

We have a strong management team with decades of industry experience and professional knowledge. By utilizing our technology and clinical expertise, we aim to develop a complete set of products that effectively treat different stages of glaucoma and enhance patient care.